Author: Kathrynne HoldenPublished: 26 January 2017
Prep: -Cook: -Serves: -
In her latest nutrition article, former National Parkinson Foundation dietician Kathrynne Holden, explains the benefits of vitamin B3 – also known as niacin – for people with young-onset Parkinson’s
Vitamin B3, or niacin, is one of the vitamins needed for human life. While it is necessary for everyone, it may have added value for people with inherited Parkinson’s disease.
In a recent research study from the University of Leicester, scientists examined the effect of niacin-rich foods on fruit flies. The flies had a genetic mutation similar to the one in people with hereditary Parkinson’s disease. They learned that the high-niacin food prevented the degeneration of neurons in the brains of the flies.
What does this mean for people with Parkinson’s disease?
We can’t assume that an animal study will apply to humans. About 75% of the DNA in fruit flies is the same as human DNA, so although flies are good research subjects, the study results are not conclusive.
However, it is still possible that niacin-rich foods could benefit people with Parkinson’s disease. As niacin is already being used in cancer studies, and in treating strokes, we can trust that increasing high-niacin foods in our diet will be safe, and may be therapeutic. It is important to note that the research indicates that natural, food-based sources of niacin/vitamin B3 are preferable, rather than supplement tablets.
How much niacin/vitamin B3 do we need daily?
The recommended daily amount (RDA) of vitamin B3 for adults is 16mg for men and 14mg for women. There is no risk of excess or toxicity from foods. However, with use of supplement tablets there is an upper limit of 35mg per day for adults. Very high doses of supplements can cause a burning sensation in the skin of the face and chest, and can increase histamine in people with allergies. Another factor to be aware of is that some people with Parkinson’s disease have orthostatic hypotension (low blood pressure) and vitamin B3 supplements can cause a dangerous drop in blood pressure.
Which foods are high in vitamin B3?
High-protein foods are the richest in vitamin B3. We must consider that people using levodopa may be sensitive to protein, and, if so, will need to carefully time medications and meals, so that the levodopa is absorbed into the bloodstream ahead of protein in the meal.
By combining servings of high-protein foods with grains, vegetables, pulses and fruits you can be certain to get plenty of vitamin B3 in your daily menu. Below is a one-day meal plan that’s high in vitamin B3.
Morning meal 1 cup cooked barley cereal with milk or milk alternative 3.2mg
1 slice whole wheat bread, toasted with butter 1.3mg
1 banana 0.67mg
Juice, milk, coffee or tea as desired
Midday meal Tuna sandwich
(with canned tuna and two slices whole wheat bread 9.6mg
Coleslaw or lettuce salad
Beverage of choice
The day’s menu exceeds the RDA for both men and women, yet is well below the upper limit of 35mg. Whether you are living with Parkinson’s or not, this is a healthy day’s menu, with a variety of foods, and ample vitamin B3.
‘Shakshuka’ is a dish of eggs poached in a sauce of tomatoes, chili peppers and onions
GyroGlove: call for volunteers to test award-winning, tremor-reducing wearable
Sign up to test the GyroGlove!
4 days ago
A “revolutionary” step in stem cell therapy for Parkinson’s disease?
Scientists in China have developed a method to help improve stem cell research in mice models of Parkinson’s – which could potentially lead to promising new treatments. The researchers, based at the Chinese Academy of Sciences, identified two cell surface markers of dopamine neurons, which are reduced in Parkinson’s. They injected cells with these markers into the brains of the mice and found that this resulted in “higher therapeutic potency” for improving motor symptoms of the condition. As part of their research, the team also worked to control the variability of donor cells, to help improve therapeutic outcomes for Parkinson’s cell therapy. The researchers, whose study was published in ‘The Journal of Clinical Investigation’, described the findings as a “revolutionary step on the road towards more effective and safer stem cell therapies”.
Could frequent nightmares be an early sign of Parkinson’s disease?
A new study has suggested that experiencing recurrent nightmares and bad dreams could be an early symptom of Parkinson’s disease. Researchers from the University of Birmingham, UK, used data from an existing US study that followed 3818 men, aged 67 or older, over a period of 12 years. Participants who reported experiencing bad dreams at least once a week were followed up. During the follow up, 91 people were diagnosed with Parkinson’s. The results suggested that participants who had frequent bad dreams were twice as likely to develop the condition as those who did not. Commenting on the study, lead author Dr Abidemi Otaiku said: “While we need to carry out further research, identifying the significance of bad dreams and nightmares could indicate that individuals who experience changes to their dreams in older age – without any obvious trigger – should seek medical advice.”
More than £2m awarded to research on mitochondria and Parkinson’s disease
Researchers at UK biotech startup NRG Therapeutics are developing potential treatments that may help slow the progression of Parkinson’s by protecting the mitochondria – a part of every human cell that works to power chemical reactions. The company has now received a £2.68m award from government-backed agency Innovate UK to continue its research. Their research built upon previous findings that damage to mitochondria in the substantia nigra – an area of the brain associated with dopamine – may be linked to Parkinson’s. The scientists developed molecules that keep a ‘pore’ in the mitochondria closed, which stops calcium flowing into it, preventing a process that eventually ruptures the powerhouse of the cell and leads to its death. The new funding award follows previous investment from Parkinson’s UK and the Michael J Fox Foundation.